{
  "experiment_id": "7d7f200d81fb321390c4b05d27f7e311",
  "task_name": "narrowing_of_broad_synonyms",
  "task_hash": "9dc5c284f909400a12e111d9ec8ba4e5",
  "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
  "system_instructions": "You are an expert metadata curation assistant specializing in biomedical and scientific data. Your task is to help improve and correct metadata according to the specific instructions provided for each task. \n\nKey principles:\n- Be precise, accurate, and follow guidelines carefully\n- Pay close attention to controlled vocabularies and schemas\n- Ensure consistency across all outputs\n- When enums or schemas are provided, use the exact values specified\n- Validate your outputs against the expected format before responding",
  "temperature": 0.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-12-11T03:42:27.020403",
  "task_result": {
    "task_name": "narrowing_of_broad_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis",
          "assay": "DNA sequencing",
          "tumorType": "Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"Neurofibromatosis\" (broad term) \u2192 \"Neurofibromatosis type 1\" (more specific)\n   - Narrowed to the most common form of neurofibromatosis, which matches the exact enum value in the schema\n\n2. **assay**: \"DNA sequencing\" (broad term) \u2192 \"whole genome sequencing\" (more specific)\n   - Narrowed to a specific type of DNA sequencing method that matches the exact enum value in the schema\n\n3. **tumorType**: \"Neurofibroma\" (already specific)\n   - This term was already appropriately specific and matches the exact enum value, so no change was needed",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3086,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 217
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01JxBGH8pDY8syVzJHRxfJMt",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"Neurofibromatosis\" (broad term) \u2192 \"Neurofibromatosis type 1\" (more specific)\n   - Narrowed to the most common form of neurofibromatosis, which matches the exact enum value in the schema\n\n2. **assay**: \"DNA sequencing\" (broad term) \u2192 \"whole genome sequencing\" (more specific)\n   - Narrowed to a specific type of DNA sequencing method that matches the exact enum value in the schema\n\n3. **tumorType**: \"Neurofibroma\" (already specific)\n   - This term was already appropriately specific and matches the exact enum value, so no change was needed"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3086,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 217
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3086,
          "output_tokens": 217,
          "total_tokens": 3303
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "NF",
          "assay": "exome sequencing",
          "tumorType": "sarcoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3080,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 54
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_016xow5SVvHktemQMxSghKGb",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3080,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 54
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3080,
          "output_tokens": 54,
          "total_tokens": 3134
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Neurofibromatoses",
          "assay": "assay by high throughput sequencer",
          "tumorType": "Nerve Sheath Neoplasm"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Rationale for narrowing:**\n\n1. **diagnosis**: \"Neurofibromatoses\" (plural, broad category) \u2192 \"Neurofibromatosis type 1\" - This is the most common form of neurofibromatosis and the most frequently studied in research contexts. NF1 is the most prevalent among the neurofibromatosis disorders.\n\n2. **assay**: \"assay by high throughput sequencer\" (broad method description) \u2192 \"whole genome sequencing\" - This is a specific high-throughput sequencing assay that is commonly used in comprehensive genomic studies. It represents a precise application of high-throughput sequencing technology.\n\n3. **tumorType**: \"Nerve Sheath Neoplasm\" (broad category) \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" - This is a specific type of nerve sheath tumor that is particularly relevant in neurofibromatosis research and represents a more precise diagnostic classification than the general term.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3095,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 286
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_018qjQQMtcABfdcXE9MJpvgG",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Rationale for narrowing:**\n\n1. **diagnosis**: \"Neurofibromatoses\" (plural, broad category) \u2192 \"Neurofibromatosis type 1\" - This is the most common form of neurofibromatosis and the most frequently studied in research contexts. NF1 is the most prevalent among the neurofibromatosis disorders.\n\n2. **assay**: \"assay by high throughput sequencer\" (broad method description) \u2192 \"whole genome sequencing\" - This is a specific high-throughput sequencing assay that is commonly used in comprehensive genomic studies. It represents a precise application of high-throughput sequencing technology.\n\n3. **tumorType**: \"Nerve Sheath Neoplasm\" (broad category) \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" - This is a specific type of nerve sheath tumor that is particularly relevant in neurofibromatosis research and represents a more precise diagnostic classification than the general term."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3095,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 286
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3095,
          "output_tokens": 286,
          "total_tokens": 3381
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurocutaneous syndrome",
          "assay": "spectroscopy",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocutaneous syndrome\" is a broad term that encompasses several conditions. In the context of the provided schema (which focuses on NF-related conditions), this has been narrowed to \"Neurofibromatosis type 1\" - the most common neurocutaneous syndrome in this domain. Note: The exact value \"Neurofibromatosis type 1\" from the enum was used.\n\n2. **assay**: \"spectroscopy\" is a general term. Based on the available enum values, this has been narrowed to \"FTIR spectroscopy\" (Fourier-Transform Infrared Spectroscopy), which is a specific spectroscopy technique commonly used in biomedical research.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact capitalization in the controlled vocabulary enum.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3080,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 250
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01Fk8JPrfKSoqYc4ZRQtruLT",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocutaneous syndrome\" is a broad term that encompasses several conditions. In the context of the provided schema (which focuses on NF-related conditions), this has been narrowed to \"Neurofibromatosis type 1\" - the most common neurocutaneous syndrome in this domain. Note: The exact value \"Neurofibromatosis type 1\" from the enum was used.\n\n2. **assay**: \"spectroscopy\" is a general term. Based on the available enum values, this has been narrowed to \"FTIR spectroscopy\" (Fourier-Transform Infrared Spectroscopy), which is a specific spectroscopy technique commonly used in biomedical research.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact capitalization in the controlled vocabulary enum."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3080,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 250
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3080,
          "output_tokens": 250,
          "total_tokens": 3330
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunoassay",
          "tumorType": "neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n- `diagnosis`: \"Not Applicable\" - No change needed (already matches exact enum value)\n- `assay`: \"immunoassay\" - No change needed (already matches exact enum value)\n- `tumorType`: \"neurofibroma\" \u2192 \"Neurofibroma\" - Corrected capitalization to match the exact controlled terminology value in the schema",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3082,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 133
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_011KxzqDPd4hDMDVRMZCdAaw",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n- `diagnosis`: \"Not Applicable\" - No change needed (already matches exact enum value)\n- `assay`: \"immunoassay\" - No change needed (already matches exact enum value)\n- `tumorType`: \"neurofibroma\" \u2192 \"Neurofibroma\" - Corrected capitalization to match the exact controlled terminology value in the schema"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3082,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 133
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3082,
          "output_tokens": 133,
          "total_tokens": 3215
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "neurofibromatosis",
          "assay": "plate based reporter assay",
          "tumorType": "benign neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis\" \u2192 \"Neurofibromatosis type 1\"\n   - Narrowed from the broad term \"neurofibromatosis\" to the more specific \"Neurofibromatosis type 1\" (NF1), which is the most common form and matches the exact enum value in the schema.\n\n2. **assay**: \"plate based reporter assay\" \u2192 \"massively parallel reporter assay\"\n   - Narrowed from the general \"plate based reporter assay\" to the more specific \"massively parallel reporter assay\" (MPRA), which is the precise controlled terminology for high-throughput reporter assays in the schema.\n\n3. **tumorType**: \"benign neurofibroma\" \u2192 \"Neurofibroma\"\n   - Narrowed from the descriptive \"benign neurofibroma\" to the standard classification \"Neurofibroma\", which is the exact enum value in the schema. The term \"benign\" is implicit in the standard neurofibroma classification.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3088,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 299
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_012VuS48J9koNdpXCt3kUZCD",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis\" \u2192 \"Neurofibromatosis type 1\"\n   - Narrowed from the broad term \"neurofibromatosis\" to the more specific \"Neurofibromatosis type 1\" (NF1), which is the most common form and matches the exact enum value in the schema.\n\n2. **assay**: \"plate based reporter assay\" \u2192 \"massively parallel reporter assay\"\n   - Narrowed from the general \"plate based reporter assay\" to the more specific \"massively parallel reporter assay\" (MPRA), which is the precise controlled terminology for high-throughput reporter assays in the schema.\n\n3. **tumorType**: \"benign neurofibroma\" \u2192 \"Neurofibroma\"\n   - Narrowed from the descriptive \"benign neurofibroma\" to the standard classification \"Neurofibroma\", which is the exact enum value in the schema. The term \"benign\" is implicit in the standard neurofibroma classification."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3088,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 299
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3088,
          "output_tokens": 299,
          "total_tokens": 3387
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "RASopathy",
          "assay": "immunoassay",
          "tumorType": "NFIB"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"RASopathy\" is a broad term referring to a group of genetic syndromes caused by mutations in the RAS/MAPK pathway. I narrowed this to \"Noonan Syndrome\", which is one of the most common RASopathies and is included in the controlled vocabulary.\n\n2. **assay**: \"immunoassay\" is already a specific term in the controlled vocabulary and matches exactly, so no change was needed.\n\n3. **tumorType**: \"NFIB\" appears to be an abbreviation or broad reference. Based on the context and available controlled terms, I narrowed this to \"Neurofibroma\", which is a specific tumor type commonly associated with neurofibromatosis conditions and is present in the controlled vocabulary.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3083,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 229
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01Lo3nDZMaHzHj8DTKNAjrBz",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"RASopathy\" is a broad term referring to a group of genetic syndromes caused by mutations in the RAS/MAPK pathway. I narrowed this to \"Noonan Syndrome\", which is one of the most common RASopathies and is included in the controlled vocabulary.\n\n2. **assay**: \"immunoassay\" is already a specific term in the controlled vocabulary and matches exactly, so no change was needed.\n\n3. **tumorType**: \"NFIB\" appears to be an abbreviation or broad reference. Based on the context and available controlled terms, I narrowed this to \"Neurofibroma\", which is a specific tumor type commonly associated with neurofibromatosis conditions and is present in the controlled vocabulary."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3083,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 229
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3083,
          "output_tokens": 229,
          "total_tokens": 3312
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "NF",
          "assay": "medical imaging",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"NF\" (broad abbreviation) \u2192 \"Neurofibromatosis type 1\" - This is the most common form of neurofibromatosis and the most likely interpretation of the abbreviation \"NF\" in clinical contexts.\n\n2. **assay**: \"medical imaging\" (broad category) \u2192 \"conventional MRI\" - MRI is the most commonly used medical imaging modality for neurofibromatosis diagnosis and monitoring, making it the most appropriate specific term from the available options.\n\n3. **tumorType**: \"unknown\" (lowercase) \u2192 \"Unknown\" - Corrected to match the exact controlled vocabulary value with proper capitalization as specified in the schema enum.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3076,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 211
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01QYHe1WBux92XWmSNWZiuPd",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"NF\" (broad abbreviation) \u2192 \"Neurofibromatosis type 1\" - This is the most common form of neurofibromatosis and the most likely interpretation of the abbreviation \"NF\" in clinical contexts.\n\n2. **assay**: \"medical imaging\" (broad category) \u2192 \"conventional MRI\" - MRI is the most commonly used medical imaging modality for neurofibromatosis diagnosis and monitoring, making it the most appropriate specific term from the available options.\n\n3. **tumorType**: \"unknown\" (lowercase) \u2192 \"Unknown\" - Corrected to match the exact controlled vocabulary value with proper capitalization as specified in the schema enum."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3076,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 211
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3076,
          "output_tokens": 211,
          "total_tokens": 3287
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "neurocristopathy",
          "assay": "transcriptomics",
          "tumorType": "neurolemmoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocristopathy\" is a broad term referring to disorders of neural crest-derived tissues. In the context of the available controlled vocabulary, this most commonly refers to **\"Neurofibromatosis type 1\"** (NF1), which is the most prevalent neurocristopathy in the schema options.\n\n2. **assay**: \"transcriptomics\" is already an exact match in the controlled vocabulary, so it remains **\"transcriptomics\"**.\n\n3. **tumorType**: \"neurolemmoma\" is an older/alternative term for schwannoma (a tumor arising from Schwann cells). The precise controlled term is **\"Schwannoma\"**.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3084,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 217
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01VXe8WJvo6d95dQkbwDVc6F",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocristopathy\" is a broad term referring to disorders of neural crest-derived tissues. In the context of the available controlled vocabulary, this most commonly refers to **\"Neurofibromatosis type 1\"** (NF1), which is the most prevalent neurocristopathy in the schema options.\n\n2. **assay**: \"transcriptomics\" is already an exact match in the controlled vocabulary, so it remains **\"transcriptomics\"**.\n\n3. **tumorType**: \"neurolemmoma\" is an older/alternative term for schwannoma (a tumor arising from Schwann cells). The precise controlled term is **\"Schwannoma\"**."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3084,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 217
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3084,
          "output_tokens": 217,
          "total_tokens": 3301
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "phakomatosis",
          "assay": "viability assay",
          "tumorType": "tumor of cranial and spinal nerves"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of narrowing:**\n\n1. **diagnosis**: \"phakomatosis\" is a broad term referring to neurocutaneous syndromes. The most common phakomatosis in the provided schema is \"Neurofibromatosis type 1\" (NF1), which is the most prevalent neurocutaneous disorder.\n\n2. **assay**: \"viability assay\" is a general term that has been narrowed to \"cell viability assay\", which is the exact controlled terminology value in the schema for assays measuring cell viability.\n\n3. **tumorType**: \"tumor of cranial and spinal nerves\" is a broad anatomical description. The most specific nerve tumor type in the schema is \"Schwannoma\", which is a tumor arising from Schwann cells of peripheral nerves, including cranial and spinal nerves.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3088,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 242
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_014w8vavXPciQEa4fc5R1yDv",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of narrowing:**\n\n1. **diagnosis**: \"phakomatosis\" is a broad term referring to neurocutaneous syndromes. The most common phakomatosis in the provided schema is \"Neurofibromatosis type 1\" (NF1), which is the most prevalent neurocutaneous disorder.\n\n2. **assay**: \"viability assay\" is a general term that has been narrowed to \"cell viability assay\", which is the exact controlled terminology value in the schema for assays measuring cell viability.\n\n3. **tumorType**: \"tumor of cranial and spinal nerves\" is a broad anatomical description. The most specific nerve tumor type in the schema is \"Schwannoma\", which is a tumor arising from Schwann cells of peripheral nerves, including cranial and spinal nerves."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3088,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 242
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3088,
          "output_tokens": 242,
          "total_tokens": 3330
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.4666666666666667,
      "min_score": 0.0,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 91.34897112846375,
    "token_usage": {
      "input_tokens": 30842,
      "output_tokens": 2138,
      "total_tokens": 32980
    }
  }
}